Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
South Australian Meningococcal B Vaccine Herd Immunity Study
NCT03089086Phase 4Completed
- Sponsor
- University of Adelaide
- Start
- Apr 2017
- Primary completion
- Jul 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group B vaccine in meningococcal disease, sponsored by University of Adelaide. Started Apr 2017; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT03089086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03089086.